60 Degrees Pharmaceuticals
(NASDAQ) SXTP
60 Degrees Pharmaceuticals Financials at a Glance
Market Cap
$4.69M
Revenue (TTM)
$1.01M
Net Income (TTM)
$7.37M
EPS (TTM)
$-15.26
P/E Ratio
-0.12
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.78
Volume
1,152
Open
$1.74
Price
$1.78
Volume
1,152
Open
$1.74
Previous Close
$1.78
Daily Range
$1.74 - $1.79
52-Week Range
$1.29 - $17.68
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.78
Volume
1,152
Open
$1.74
Previous Close
$1.78
Daily Range
$1.74 - $1.79
52-Week Range
$1.29 - $17.68
SXTP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 60 Degrees Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
5
CEO
Geoffrey S. Dow, PhD, MBA
Website
60degreespharma.comHeadquarters
Washington, DC 20036, US
SXTP Financials
Key Financial Metrics (TTM)
Gross Margin
22%
Operating Margin
-8%
Net Income Margin
-7%
Return on Equity
-196%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-8.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.69M
Shares Outstanding
2.64M
Volume
1.15K
Short Interest
0.00%
Avg. Volume
4.52M
Financials (TTM)
Gross Profit
$223.78K
Operating Income
$7.76M
EBITDA
$7.28M
Operating Cash Flow
$6.85M
Capital Expenditure
$218.08K
Free Cash Flow
$7.07M
Cash & ST Invst.
$2.75M
Total Debt
$152.78K
60 Degrees Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$303.38K
+16.0%
Gross Profit
$182.70K
+27.4%
Gross Margin
60.22%
N/A
Market Cap
$4.69M
N/A
Market Cap/Employee
$1.56M
N/A
Employees
3
N/A
Net Income
$1.44M
+29.7%
EBITDA
$1.41M
+30.4%
Quarterly Fundamentals
Net Cash
$2.60M
-19.6%
Accounts Receivable
$509.64K
+4.7%
Inventory
$656.92K
+48.4%
Long Term Debt
$144.00K
-2.1%
Short Term Debt
$8.77K
+0.0%
Return on Assets
-1.37%
N/A
Return on Invested Capital
-2.20%
N/A
Free Cash Flow
$4.71M
-187.0%
Operating Cash Flow
$4.64M
-183.5%